Showing 741 - 760 results of 1,182 for search '"liver disease"', query time: 0.08s Refine Results
  1. 741

    Lack of adipocyte FAM20C improves whole body glucose homeostasis by Liping Deng, Yanshan Huang, Feifei Zhao, Puxin Chen, Xiaohong Huang

    Published 2024-11-01
    “…Our results demonstrate that knockout mice are protected against high fat diet‐induced obesity, adiposity, and fatty liver disease. Additionally, knockout mice exhibited improved metabolic phenotypes, including enhanced glucose tolerance and insulin sensitivity compared with control mice. …”
    Get full text
    Article
  2. 742

    Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat by Nazar M. Shareef Mahmood

    Published 2022-01-01
    “…Paraquat (PQ), as a frequently used compound in many applications while the  herbal providing is vigorously used in the curing of broad spectrum diseases such as liver disease, the influence of thyme extract or Thymus vulgaris L. …”
    Get full text
    Article
  3. 743

    Microbiome interplays in the gut-liver axis: implications for liver cancer pathogenesis and therapeutic insights by Xuran Wang, Bin Zhang, Runqiu Jiang

    Published 2025-01-01
    “…With the advancement of modern medical research and care system, the main etiology of PLC more and more switches from hepatitis viruses such as HAV, HBV, HCV, HEV to other causes like metabolism-associated steatohepatitis (MASH) and metabolic-associated fatty liver disease (MAFLD). As a result, it is of great necessity to find out new ways for treatment and early diagnosis to cope with this problem. …”
    Get full text
    Article
  4. 744

    Liver Injury with Features Mimicking Autoimmune Hepatitis following the Use of Black Cohosh by Grace Guzman, Eric R. Kallwitz, Christina Wojewoda, Rohini Chennuri, Jamie Berkes, Thomas J. Layden, Scott J. Cotler

    Published 2009-01-01
    “…Both patients reported black cohosh use for at least six months and had no evidence of another cause of liver disease. Their liver biopsies showed a component of centrilobular necrosis consistent with severe drug-induced liver injury. …”
    Get full text
    Article
  5. 745

    Protective Effect of Vitamin E on Gastric Mucosal Injury in Rats with Biliary Obstruction by Nuh Zafer Cantürk, Zeynep Cantürk, G Özbilim, C Yenisey

    Published 2000-01-01
    “…Patients with liver disease display increased susceptibility to gastric mucosal damage. …”
    Get full text
    Article
  6. 746

    Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat by Nazar M. Shareef Mahmood

    Published 2022-01-01
    “…Paraquat (PQ), as a frequently used compound in many applications while the  herbal providing is vigorously used in the curing of broad spectrum diseases such as liver disease, the influence of thyme extract or Thymus vulgaris L. …”
    Get full text
    Article
  7. 747

    Transition from Hepatopulmonary Syndrome to Portopulmonary Hypertension: A Case Series of 3 Patients by Radhika Zopey, Irawan Susanto, Igor Barjaktarevic, Tisha Wang

    Published 2013-01-01
    “…Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are the two major pulmonary vascular complications of liver disease. While HPS is characterized by low pulmonary vascular resistance, PPHTN is defined by the presence of elevated pulmonary vascular resistance. …”
    Get full text
    Article
  8. 748
  9. 749

    PreS1 deletions in genotype C HBV leads to severe hepatic inflammation and hepatocarcinogenesis via the IRE1-JNK axis by Yu-Min Choi, Junghwa Jang, Dong Hyun Kim, Ziyun Kim, Eunseo Kim, Won Hyeok Choe, Bum-Joon Kim

    Published 2025-03-01
    “…We investigated the mechanism by which preS1Del is related to liver disease progression and enhanced HBV replication, focusing on endoplasmic reticulum (ER) stress. …”
    Get full text
    Article
  10. 750

    Helicobacter mastomyrinus infection induces autoimmune hepatitis in mice by Liqi Zhu, Yuanyuan Liang, Linghan Yang, Qihui Yang, Jun Yin, Tao Wang, Xiangming Xu, Quan Zhang

    Published 2025-06-01
    “…Abstracts: Background: Autoimmune hepatitis (AIH) is a chronic progressive liver disease caused by the immune system mistakenly attacking its own hepatocytes. …”
    Get full text
    Article
  11. 751

    Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives by James C. Barton, J. Clayborn Barton

    Published 2015-01-01
    “…We performed a retrospective study of autoimmune conditions (ACs) in 235 hemochromatosis probands at diagnosis by analyzing age, sex, ACs, history of first-degree family members with ACs (FH), diabetes, heavy ethanol consumption, elevated serum ALT/AST, nonalcoholic fatty liver disease, viral hepatitis, cirrhosis, iron removed to achieve iron depletion (QFe), and positivity for human leukocyte antigen (HLA) haplotypes A∗01, B∗08; A∗02, B∗44; A∗03, B∗07; A∗03, B∗14; and A∗29, B∗44. …”
    Get full text
    Article
  12. 752

    Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago by Lan Dam, Anita Cheng, Phuong Tran, Shirley S. Wong, Ronald Hershow, Sheldon Cotler, Scott J. Cotler

    Published 2016-01-01
    “…Stigma regarding viral hepatitis and liver disease has psychological and social consequences including causing negative self-image, disrupting relationships, and providing a barrier to prevention, testing, and treatment. …”
    Get full text
    Article
  13. 753

    Improving Survival in Decompensated Cirrhosis by Amar Nath Mukerji, Vishal Patel, Ashokkumar Jain

    Published 2012-01-01
    “…Organ allocation is prioritized for the sickest patients based on Model for End Stage Liver Disease (MELD) score. In order to improve survival in patients with high MELD score it is imperative to preserve them in suitable condition till transplantation. …”
    Get full text
    Article
  14. 754

    Cardiac Failure after Liver Transplantation Requiring a Biventricular Assist Device by Rita Jermyn, Eiei Soe, David D’Alessandro, Julia Shin, William Jakobleff, Daniel Schwartz, Milan Kinkhabwala, Paul J. Gaglio

    Published 2014-01-01
    “…This case highlights the importance of preoperatively recognizing extrahepatic iron deposition in patients referred for liver transplantation irrespective of etiology of liver disease as this may prevent postoperative complications.…”
    Get full text
    Article
  15. 755

    Prevalence of advanced hepatic fibrosis and individualization of associated risk factors by Bayesian analysis in MASLD patients in French cardio-metabolic health networks. by Michel Doffoel, Frédéric Chaffraix, Archia Chahard, Dominique Gras, Odile Bonomi, Corinne Bildstein, Simona Tripon, Maude Royant, Nicolas Meyer

    Published 2025-01-01
    “…The aim of this study was to determine the prevalence of advanced hepatic fibrosis and to individualize using Bayesian analysis its associated risk factors in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) being cared for in three Alsatian cardio-metabolic health networks in the North East of France. …”
    Get full text
    Article
  16. 756

    Quality of Life of Patients with Liver Cirrhosis by María Belén Alvarado Villavicencio, Evelyn Carolina Betancourt Rubio, Luis Roberto Villamarín Ponce

    Published 2023-11-01
    “…<strong>Foundation: l</strong>iver cirrhosis is a chronic liver disease characterized by the formation of scar tissue and a decrease in normal liver function. …”
    Get full text
    Article
  17. 757

    Apelin Serum Level in Egyptian Patients with Chronic Hepatitis C by Hala O. El-Mesallamy, Nadia M. Hamdy, Hanan H. Rizk, Abdel-Rahman El-Zayadi

    Published 2011-01-01
    “…Highlighting the apelin system would present a new therapeutic target for liver disease. Apelin; endogenous ligand for the orphan receptor APJ, was recently suggested to be associated with fibrosis progression and cirrhosis in addition to insulin resistance (IR) and inflammation. …”
    Get full text
    Article
  18. 758

    New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications by Eva Sticova, Milan Jirsa, Joanna Pawłowska

    Published 2018-01-01
    “…Phenotypic manifestation is highly variable, ranging from progressive familial intrahepatic cholestasis (PFIC)—with onset in early infancy and progression to end-stage liver disease—to a milder intermittent mostly nonprogressive form known as benign recurrent intrahepatic cholestasis (BRIC). …”
    Get full text
    Article
  19. 759

    Systematic Framework to Predict Early-Stage Liver Carcinoma Using Hybrid of Feature Selection Techniques and Regression Techniques by Marium Mehmood, Nasser Alshammari, Saad Awadh Alanazi, Fahad Ahmad

    Published 2022-01-01
    “…The liver is the human body’s mandatory organ, but detecting liver disease at an early stage is very difficult due to the hiddenness of symptoms. …”
    Get full text
    Article
  20. 760

    Noncoding RNAs Associated with PPARs in Etiology of MAFLD as a Novel Approach for Therapeutics Targets by Fatemeh Kazeminasab, Maryam Baharlooie, Kamran Ghaedi

    Published 2022-01-01
    “…Metabolic associated fatty liver disease (MAFLD) is a complex disease that results from the accumulation of fat in the liver. …”
    Get full text
    Article